See the Current CDC COVID-19 Recommendations Learn More

Doctors

Arturo J. Bonnin, MD

CURRICULAM VITAE

Name: Arturo J. Bonnin, M.D.
Telephone: Office - (937) 435-8999
Citizenship: United States of America
Marital Status: Married
Children: Four

PRACTICE AND POSITIONS:

1996 - Present President, Ohio Allergy Associates, Inc.
1992 - Present Allergy & Asthma Centre of Dayton, Ohio, USA
(Private Practice)

CURRENT HOSPITAL PRIVILEGES:

1993 - Present Children's Medical Center, Dayton, Ohio, USA
1992 - Present Miami Valley Hospital, Dayton, Ohio, USA
Kettering Medical Center, Kettering, Ohio, USA

FACULTY APPOINTMENTS:

2009 - Present Clinical Assistant Professor of Allergy/Immunology, Ohio University College of Osteopathic Medicine, Athens, Ohio, USA
2004 - Present Associated Clinical Professor of Internal Medicine, Boonshoft School of Medicine at Wright State University. Dayton, Ohio, USA
1995 - 2003 Assistant Clinical Professor of Internal Medicine, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA
1991 - 1992 Instructor of Immunology, Rush Medical College, Chicago, Illinois, USA

POSTGRADUATE TRAINING:

1989 - 1991 Fellowship in Allergy and Clinical Immunology at Rush-Presbyterian St. Luke's Medical Center, Chicago, Illinois, USA
1986 - 1989 Residency in Internal Medicine, Damas Hospital, Ponce, Puerto Rico, USA
1985 - 1986 Transitional Residency, Damas Hospital, Ponce, Puerto Rico, USA

CERTIFICATIONS:

2013 American Board of Allergy and Immunology (Recertification); valid until Dec 2023, #3502
2003 American Board of Allergy and Immunology (Recertification); 2003 #3502
1993 American Board of Allergy and Immunology; 1993, #3502
1990 American Board of Internal Medicine; 1990 expired in 2000, # 125062
1988 Federal License Examination (FLEX); valid indefinitely, #570902022
1988 Educational Commission for Foreign Medical Graduates (ECFMG), Standard Certificate; valid indefinitely, #280-190-9
1986 Puerto Rico Medical boards; valid indefinitely

COMMITTEE MEMBERSHIP:

2009 - Present Mechanism of Asthma and Allergic Inflammation Interest Section, AAAAI
1998 - Present Allergy, Immunology and Inflammation Assembly, ATS
1994 - 2002 Credential Committee United Health Care of Ohio, Inc.
1998 - 1999 Committee for Asthma and Respiratory Diseases, ACAAI
1997 - 1999 National Physician Evaluators for Ethix Midlands (New York Life)
1996 - 1999 Medical Advisory Committees, Ethix Midlands (New York Life)
1995 - 1999 Consultant to the Ethix Asthma Disease Management Program

PROFESSIONAL MEMBERSHIPS:

1996 - Present American Thoracic Society
1993 - Present American Academy of Allergy, Asthma and Immunology, Fellow
1992 - Present Ohio State Medical Association
Montgomery County Medical Society
1990 - Present American College of Allergy, Asthma and Immunology, Fellow
Joint Council of Allergy and Immunology

MEDICAL EDUCATION:

1978 - 1985 "Licenciado en Medicina y Cirugia," M.D.
University of Navarra, Pamplona, Navarra, Spain

PREMEDICAL EDUCATION:

1976 - 1978 Georgia Institute of Technology, Physics Major, Atlanta, Georgia, USA
1975 - 1976 University of Puerto Rico, Physics Major, Ponce, Puerto Rico, USA

TEACHING EXPERIENCE:

2009 - Present Outpatient Rotation for fourth year Osteopathic Medical Student from Ohio University
1997 - Present Outpatient Rotation for Third Year Family Medicine Residents from The Dayton Community Family Practice Residency Program
1995 - 2009 Outpatient Rotation for Second Year Internal Medicine Residents from Miami Valley Hospital.
1990 Basic Immunology Course for Summer Students; Rush Medical College, Chicago, Illinois, USA
1989 Basic Electrocardiography Course for Nurses, Damas Hospital, Ponce, Puerto Rico, USA
1988 Clinical Correlation’s for Second Year Medical Students, Ponce School of Medicine, Ponce, Puerto Rico, USA
1987 Clinical Correlation’s for Second Year Medical Students, Ponce School of Medicine, Ponce, Puerto Rico, USA
1977 Teaching Assistant, Physics Department, Georgia Institute of Technology, Atlanta, Georgia, USA

RESEARCH:
EXPERIENCE AND PRESENTATIONS

2013 - 2015 Protocol ML 28528-A Prospective observational study to evaluate predictors of clinical effectiveness in response to omalizumab. PI at local site: Arturo J. Bonnin, M.D. Sponsored by Genentech
2012 - 2015 Protocol GB28689-A Phase III, randomized, double-blind, placebo-controlled study to assess the efficiacy and safety of lebrinkizumab in patients with uncontrolled asthma who are on inhaled corticosteroids and a second controller medication. PI at local site: Arturo J. Bonnin. Sponsored by Genentech. Published at: Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (Lavolta I and Lavolta II). Lancet 2016;4:781-96
2012 - 2014 Protocol SAS115358-A Phase IV, randomized study to evaluate safety and benefit of inhaled Fluticasone Propionate/salmeterol combinations versus inhaled Fluticasone propionate in the treatment of Pediatric Subjects 4-11 years old with persistent asthma. PI at local site: Arturo J. Bonnin, M.D., Sponsored by GlaxoSmithKline. Published at: Safety of Adding Salmeterol to Futicasone Propionate in Children with Asthma. N Engl J Med. 2016 Sep 1; 375(9):840-9
2012 - 2013 Protocol GB27980-A Phase IIB, randomized, double blind, placebo controlled study to evaluate the efficacy, safety and dosing regimens of MEMP1972A in adults with allergic asthma who are inadequately controlled on inhaled corticosteroids and a second controller medication. PI at local site: Arturo J. Bonnin, M.D., Sponsored by Genentech.
2012 - 2013 Protocol GB27864-A Phase IIb, randomized double-blind, placebo-controlled study to assess the efficacy and safety of lebrikizumab in patients with uncontrolled asthma who are on inhaled corticosteroids and a second controller medication. PI at local site: Arturo J. Bonnin, M.D., Sponsored by Genentech
2011 - Present XPORT Study - Phase IV multicenter, randomized, double-blind, placebo-controlled study evaluating the persistency of response with or without Xolair after long term therapy. PI at local site: Arturo J. Bonnin, M.D., Sponsored by Genentech. Published at: A randomized multicenter study evaluating Xolair persistence of response after long-term therapy. J Allergy Clin Immunol 2017;140:162-9.
2008 - 2009 Protocol Vo61.08 - Quintiles SLIT Study: A randomized, double-blind, placebo-controlled, multi center, Phase III study of the efficacy and safety of 300 IR sublingual immunotherapy (SLIT) administered as allergen based tablets once daily to adult patients suffering from grass pollen rhinoconjunctivitis. PI at local site: Arturo J. Bonnin M.D., Sponsored by Stallergenes S.A
2008 - 2009 Protocol P04828 - Asmanex Study: A Study of The Therapeutic Equivalency of MF DPI 100 mcg and 200 mcg Inhalers in Corticosteroid-Dependent Subjects with Moderate Asthma. PI at local site: Arturo J. Bonnin M.D., Sponsored by Schering Plough.
2007 - 2008 Protocol LEVP2006-1: CHANGE 2 Trial (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation evaluating Efficacy): Open-Label Safety/Efficacy Repeat Exposure Study of C1 Esterase Inhibitor (Human) in the Treatment of Acute Hereditary Angioedema (HAE) Attacks. PI at local site: Arturo J. Bonnin, M.D. Sponsored by Lev Pharmaceuticals, Inc.
2006 - 2007 CHARIOT Study - Characterization of Allergic Asthma: A Chart Review in Moderate to Severe Disease to Assess Asthma Control, Allergies, Patient Outcomes and Treatment Study. PI at local site: Arturo J. Bonnin, M.D. Sponsored by Novartis.
2006 - 2011 EXCELS Study - Evaluation of Xolair’s Clinical Effectiveness and Long-term S afety. Five years Phase IV study. PI at local site: Arturo J. Bonnin,M.D., Sponsored by Genentech and Novartis. Published at: Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. J Allergy Clin Immunol. 2014 Sept;134(3):560-567.
1994 Bonnin AJ, Richmond, GW, Pool M, Gewurz, AT. Primary Hepatocellular Carcinoma in a patient with X-linked hypogammaglobulinemia. Rush-Pres-byterian-St. Luke's Medical Center, Chicago, Illinois, USA. Presented at the XV International Congress of Allergology and Clinical Immunology – An-nual meeting of the European Academy of Allergology and Clinical Imm-unology, Stockholm. Sweden, June 1994.
1991 Bonnin AJ, Moy JN, Richmond GW, Musto PK, Volgman AS. Lack of induction of Arrhythmias by repeated inhalation of nebulized albuterol in a patient with Wolff-Parkinson-White Syndrome and Asthma. Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA. Presented at the 48th Annual Meeting of the American College of Allergy and Immunology, New York. New York. USA. November 1991.
1991 Bonnin AJ, Moy JN, Richmond GW, Musto PK, Volgman AS. Lack of induction of Arrhythmias by repeated inhalation of nebulized albuterol in a patient with Wolff-Parkinson-White Syndrome and Asthma. Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA. Presented at the 48th Annual Meeting of the American College of Allergy and Immunology, New York. New York. USA. November 1991.
1991 Bonnin AJ and Gewurz AT. Binding of Serum Amyloid P components (SAP) to immobilized DNA: A study in patients with systemic lupus erythematosus. Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA. Presented at the 47th Annual Meeting of the American Academy of Allergy and Immunology. San Francisco, California, USA, March 1991.
1990 Bonnin AJ, Luskin AT, Zeitz HJ, and Gewurz AT. Factor I deficiency with recurrent aseptic meningitis. Rush-Presbyterian-St. Luke's Medical Center/ Max Samter Institute, Chicago, Illinois, USA. Presented at the 47th annual meeting of the American College of Allergy and Immunology, San Francisco, California, USA, November 1990.
1989 Bonnin AJ, Gewurz AT. Transferfactor therapy of chronic fatigue syndrome. Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA. Presented at the Illinois Society of Allergy and Clinical Immunology, Case Presentation Meeting. Chicago, Illinois, USA, January 1990.
1989 Bonnin AJ, Zech J. Chudwin D, Richmond GW, Gewurz AT. The association of atypical skin lesions with hypogammaglobulinemia. Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA. Presented at the 46th Annual Meeting of the American Academy of Allergy and Immunology. Baltimore, Maryland, USA, March 1990.
1988 Bonnin AJ, Montealegre F. Gewurz, AT. Elevated serum IgE in Puerto Rican Hispanics: Association with cigarette smoking. Damas Hospital, Ponce, Puerto Rico, USA. Presented at the 47th Annual Meeting of the American College of Allergy and Immunology. San Francisco. California. USA. November 1989

BIBLIOGRAPHY:

Publications - Articles:

  1. Bonnin AJ, Montealegre F, Gewurz AT. The association of cigarette smoking with elevated serum IgE levels in Hispanic Puerto Rican males. Ann Allergy. 1991 Dec;67(6):609-11.
  2. Bonnin AJ, Richmond GW, Musto PK, Volgman AS, Moy JN. Repeated inhalation of nebulized albuterol did not induce arrhythmias in a patient with Wolff-Parkinson-White Syndrome and asthma. Chest. 1993 Jun;103(6):1892-4.
  3. Bonnin AJ, Zeitz HJ, Gewurz AT. Factor I deficiency with recurrent aseptic meningitis. Arch Intern Med. 1993 Jun 14;153(11):1380-3.
  4. Zech JR, Kroger E, Bonnin AJ, Richmond GW. Sarcoidosis: An unusual cause of rectal mass. South Med J 1993 Sept;86(9):1054-5.
  5. Bonnin AJ. Mild Asthma. N Engl. J Med 2002 Apr 25;346(17):1335-6.
  6. Bonnin AJ, Zacharias DM. Sublingual Immunotherapy. N Engl. J Med 2008 Aug 21; 359(8):869-70.
  7. Powe D, Bonnin AJ, Jones N. Entopy: Local Allergy Paradigm. Clin Exp Allergy 2010 July 40 (7):987-97.
  8. Bernstein JA, Coleman S, Bonnin AJ. Successful C1 inhibitor short-term prophylaxis
    During redo mitral valve replacement in a patient with hereditary angioedema.     Journal of Cardiothoracic Surgery. 2010 Oct 18;5:86.
  9. 9. Bonnin AJ, DeBrosse CW, Moncrief TM, Richmond GW. Case report presenting the diagnostic challenges in a patient with recurrent acquired angioedema antiphospholipid antibodies and undetectable and undetectable C2 levels. Allergy Asthma Clin Immunol (2018) 14:24.

Publications - Abstracts:

  1. Bonnin AJ, Zech J. Chudwin D, Richmond GW, Gewurz AT. The association of atypical skin lesions with hypogammaglobulinemia. J Allergy Clin Immunol 1990; 85:177.
  2. Bonnin AJ, Montealegre F. Gewurz AT. Elevated serum IgE in Puerto Rican Hispanics: Association with Cigarette Smoking Ann Allergy 1991; 66:87.
  3. Bonnin AJ, Luskin AT, Zeitz HJ, Gewurz AT. Factor I deficiency with recurrent aseptic meningitis. Ann Allergy 1991; 66:84.
  4. Bonnin AJ, Gewurz AT. Binding of serum Amyloid P component (SAP) to immobilized DNA: A study in patients with systemic lupus erythematosus. J Allergy Clin Immunol 1991; 87:160.
  5. Bonnin AJ, Moy JN, Richmond GW, Musto PK, Volgman AS. Lack of induction of arrhythmias by repeated inhalation of nebulized albuterol in a patient with Wolff-Parkinson-White Syndrome and asthma. Ann Allergy 1992; 68:98.
  6. Bonnin AJ, Richmond GW, Gewurz AT. Primary hepatocellular carcinoma in a patient with X-linked hypogammaglobulinemia. Allergy and Clinical Immunology News 1994; 2:192.
  7. DeBrosse CW, Moncrief TM, Bonnin AJ. Steroid Induced Acne Secondary to Low Dose Inhaled Corticosteroids in a Pediatric Patient and Resolution with Every Other Day ICS Dosing. JACI 2017:139:98

Talks Given in the Community:

  1. Talk given to Miami Valley Pharmaceutical Association. Topic: Treating Asthma and Allergy, Dayton, Ohio, January 12, 1994.
  2. Presentation for Senior Care (service for older adults) on asthma, allergy, and sinuses. Dayton, Ohio, October 24, 1994.
  3. Presentation for Senior Care (services for older adults) on asthma and allergies. Dayton, Ohio, April 27, 1995.
  4. Talk given about allergic rhinitis, bronchial asthma, and atopic eczema for the Environmental Doctor Company, Dayton, Ohio, October 1995.
  5. Talk given to NYL Care Health Plan Staff about "Bronchial asthma", Columbus, Ohio, August 26, 1998.

Grand Rounds:

  1. "New Advances in Asthma", at Grandview Hospital, Dayton, Ohio, April 23, 1993.
  2. "Systemic Lupus Erythematosus", at Good Samaritan Hospital, Dayton, Ohio, February 8, 1994.
  3. "Chronic Urticaria and Angioedema", at St. Elizabeth Medical Center, Dayton, Ohio, 1994.
  4. "Chronic Urticaria and Angioedema", at VA Medical Center, Dayton, Ohio, May 16, 1995
  5. "Anaphylaxis", at Miami Valley Hospital, Dayton, Ohio, June 21, 1995.
  6. "Controversial Procedures in Allergy", at Miami Valley Hospital, Dayton, Ohio, April 17, 1996.
  7. "The Truth about Food Allergies", at Miami Valley Hospital, Dayton, Ohio, May 22, 1997.
  8. "Review of New National Heart, Blood, and Lung Institute Guidelines for Management of Asthma", at Miami Valley Hospital, Dayton, Ohio, November 20, 1997.
  9. "Angioedema and Urticaria", at Miami Valley Hospital, Dayton, Ohio, January 22, 1998.
  10. "Evaluating Anaphylaxis", at Miami Valley Hospital, Dayton, Ohio, February 19, 1998.
  11. "Updates in Asthma Care" at Good Samaritan Hospital, Dayton, Ohio, April 30, 2001.
  12. "Overview in Allergic Rhinitis" at Grandview Hospital, Dayton, Ohio, September 12, 2001.
  13. "Advances in Asthma: From Etiology to Treatment" at Wayne Hospital, Greenville, Ohio, April 23, 2002.
  14. "Advances in Asthma" at Miami Valley Hospital, Dayton, Ohio, June 19, 2002.
    Allergic and Non- Allergic Rhinitis and its effect on Bronchial Asthma" at Good Samaritan Hospital, Dayton, Ohio, September 23, 2002.
  15. "Allergic and Non- Allergic Rhinitis and its effect on Bronchial Asthma" at Good Samaritan Hospital, Dayton, Ohio, September 23, 2002.
  16. "New Therapies in Bronchial Asthma", at The VA Medical Center, Dayton, Ohio, September 3, 2003.
  17. "Anti-IgE and other biologic treatments for Asthma", at Kettering Medical Center, Dayton, Ohio, May 20, 2005.
  18. "Current and future treatments of Bronchial Asthma", at The VA Medical Center, Dayton, Ohio, August 31, 2005.
  19. "Anti-IgE and other immunomodulators therapy in Asthma", at Miami Valley Hospital Dayton, Ohio, October 5, 2005.
  20. "Allergy, Asthma and Anti-IgE" at Wright Patterson Air Force Base, Dayton, Ohio, February 1, 2007.
  21. "Management and Treatment of Asthma: Guidelines, Updates and Implications for IgE Mediated Therapy" at Wright Patterson Air Force Base, Dayton, Ohio September 18, 2008.

Other Medical Talks:

  1. "Food Allergy" presented to internal medicine residents at Kettering Medical Center, Dayton, Ohio, June 8, 1995.
  2. "Answers to Common Questions in the Treatment of Allergic Rhinitis and Asthma," presented to local family physicians, sponsored by Astra Pharmaceuticals, Dayton, Ohio, September 20, 1995.
  3. "New Advances in Bronchial Asthma," presented to internal medicine residents at Miami Valley Hospital, Dayton, Ohio, 1995.
  4. "Clinical Approaches to Common Problems in Seasonal Allergic Rhinitis and Asthma," presented to local family physicians, Dayton, Ohio, April 12, 1996.
  5. Teleconference moderator for the "Delivery Devices and Oral Inhaled Corticosteroids-Clinical Update in Asthma Management Program." Sponsored by Schering/Key Pharmaceuticals, Dayton, Ohio, 1996.
  6. Phase IV Research Results from Two Recently Completed Multi-Centered Comparative Trials of Oral Inhaled Steroids," presented to local physicians, Dayton, Ohio, May 24, 1996.
  7. "Common Problems in the Treatment of Allergic Rhinitis," presented to local physicians. Sponsored by Pfizer Pharmaceutical, Dayton, Ohio, April 10, 1997.
  8. "Leukotriene Antagonists and Inhibitors in Asthma." Advance in Internal Medicine 1997, presented to medical students, Wright State University, Dayton, Ohio, May 7, 1997.
  9. "Urticaria" presented to family medicine residents, Good Samaritan Hospital, Dayton, Ohio, July 16, 1997.
  10. "Clinical Approach to Allergic Rhinitis," presented to local physicians. Sponsored by Wallace Laboratories, Dayton, Ohio, August 25, 1997.
  11. "Treatment of Asthma and Allergy," presented to local physicians. Sponsored by Pfizer Pharmaceuticals, Dayton, Ohio, October 1, 1997.
  12. "The Use of the New Leukotrienes," presented to family medicine residents , Good Samaritan Hospital, Dayton, Ohio, December 10, 1997.
  13. Merck Asthma Investigator Registry Program (Air Program) sponsored by Merck Pharmaceuticals, Dayton, Ohio, March 11, 1998.
  14. "New Concepts in Allergic Rhinitis," presented to family practice physicians. Sponsored by Pfizer Pharmaceuticals, Dayton, Ohio, and June 10, 1998.
  15. "NIH Asthma Guidelines" presented to Internal Medicine Residents, Miami Valley Hospital, Dayton, Ohio, June 1, 1998.
  16. "Allergic Rhinitis Overview" presented to medical students and residents, Grandview Hospital, Dayton, Ohio, September 21, 1998.
  17. "Management of Allergic Rhinitis" presented to primary care physicians. Sponsored by Pfizer Pharmaceuticals, Dayton, Ohio, and October 22, 1998.
  18. "Leukotriene Modifiers in the Treatment of Asthma", presented to primary care physicians. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, December 5, 1998.
  19. "Role of Leukotrienes in Asthma", presented to primary care physicians. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, April 14, 1999.
  20. "New Approach for the Diagnosis and Management of Asthma", presented to primary care physicians. Sponsored by Astra-Zeneca Pharmaceutical, Dayton, Ohio, April 28, 1999.
  21. "Update on Asthma", presented to primary care physicians. Sponsored by Astra-Zeneca Pharmaceuticals, Dayton, Ohio, June 9, 1999.
  22. "New Directions in the Treatment of Asthma", presented to primary care physicians. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, September 23, 1999.
  23. "Overview of Allergic Rhinitis", presented to primary care physicians. Sponsored by Astra-Zeneca Pharmaceuticals, Dayton, Ohio, January 26, 2000.
  24. "Diagnosis and Management of Allergic Rhinitis: Putting the Treatment and Parameters into Practice", presented to primary care physicians. Sponsored by Aventis Pharmaceuticals, Dayton, Ohio, April 12, 2000.
  25. "Asthma: Diagnosis and Treatment", presented to Glaxo-Wellcome Marketing Department base, Columbus, Ohio, June 7, 2000.
  26. "The treatment of Allergic Rhinitis Using Antihistamine and Nasal Inhaled Steroid Therapies", presented to primary care physicians. Sponsored by Schering Pharmaceuticals, Springfield, Ohio, July 8, 2000.
  27. "Treatment of Allergic Rhinitis", presented to primary care physicians. Sponsored by Aventis Pharmaceuticals, Cincinnati, Ohio, July 8, 2000.
  28. "Review of Proper Treatment of Asthma: Review of the NIH Guidelines" presented to primary care physicians. Sponsored by Glaxo-Wellcome Pharmaceuticals, Dayton, Ohio, August 10, 2000.
  29. "Update on the NIH Guidelines in the Treatment of Asthma", presented to primary care physicians. Sponsored by Glaxo-Wellcome Pharmaceuticals, Dayton, Ohio, August 11, 2000.
  30. "New Guidelines for Diagnosing and Managing Allergic Rhinitis", presented to primary care physicians. Sponsored by Aventis Pharmaceuticals, Dayton, Ohio, September 6, 2000.
  31. "Asthma: Innovation in Dry Powder Inhalers", presented to primary care physicians. Sponsored by Glaxo-Wellcome Pharmaceuticals, Dayton, Ohio, November 4, 2000.
  32. "New Treatment for Asthma" a Case Study Review, presented to primary care physicians. Sponsored by Glaxo-Wellcome Pharmaceuticals, Dayton, Ohio, Nov 6, 2000.
  33. "Asthma: A Dual Component Disease and a New Therapeutic Approach to Treatment", presented to primary care physicians. Sponsored by Glaxo-Wellcome Pharmaceuticals, Dayton, Ohio, November 8, 2000.
  34. "Asthma Update", presented to primary care physicians, Sponsored by Glaxo-Wellcome Pharmaceuticals, Dayton, Ohio, November 15, 2000.
  35. "Overview of Allergic Rhinitis and Asthma", present to primary care physicians. Sponsored by Aventis Pharmaceuticals, Dayton, Ohio, January 26, 2001.
  36. "Practical aspects of topical corticosteroids in Allergic Rhinitis and Asthma", presented to primary care physicians. Sponsored by AstraZeneca, Cincinnati, Ohio, February 16, 2001.
  37. "Advair: A new drug to treat Inflammation and Bronchoconstriction", presented to primary care physicians. Sponsored by Glaxo-SmithKline Pharmaceuticals, Dayton, Ohio, March 20, 2001.
  38. "New Therapies for Asthma", presented to primary care physicians. Sponsored by Glaxo Smith Kline Pharmaceuticals, Dayton, Ohio, April 6, 2001.
  39. "New Asthma Treatment", Presented to primary care and specialists. Sponsored by Glaxo SmithKline Pharmaceuticals, Dayton, Ohio, May 26, 2001.
  40. "New Directions in the Treatment of Asthma", prsented to primary care physicians. Sponsored by Merck Pharmaceuticals, Dayton , Ohio, July 12, 2001.
  41. "Treatment of Allergic Rhinitis", presented to primary care physicians. Sponsored by Aventis Pharmaceuticals Respiratory Disease National Visiting Professors Program, Cincinnati, Ohio, July 14, 2001.
  42. "New Directions in the Treatment of Asthma", presented to primary care physicians. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, September 20, 2001.
  43. "Asthma Physiology and Management", presented to Miami Valley Hospital Internal Medicine residents. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, September 26, 2001.
  44. "Allergic Rhinitis: Questions and Answers", presented to primary care physicians. Sponsored by Pfizer Pharmaceuticals, Dayton, Ohio, September 26, 2001.
  45. "Advances in Allergy", presented to primary care physician. Sponsored by Key Pharmaceuticals and Schering Laboratories, Dayton, Ohio, October 18, 2001.
  46. "An Update on the Treatment of Allergic Rhinitis", presented to primary care physicians. Sponsored by Pfizer Pharmaceuticals, Dayton, Ohio, October 25, 2001.
  47. "New Directions in the Treatment of Asthma", presented to primary care physicians. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, November 13, 2001.
  48. "Answer and Question" about Allergic Rhinitis and Asthma, presented to medical students and primary care physician. Sponsored by GlaxoSmithKline Pharmaceutical, Dayton, Ohio, December 20, 2001.
  49. "New Treatment Options for Seasonal Allergic Rhinitis", presented to primary care physicians and otolaryngologists. Sponsored by Schering/Key Pharmaceuticals, Dayton, Ohio, February 21, 2002.
  50. "Allergic and Non-Allergic Rhinitis and the role of Intranasal Steroids" , presented to pharmacists, primary care physicians, allergists and pulmonologists, Sponsored by GlaxoSmithKline Pharmaceuticals, Springfield, Ohio, March 17, 2002.
  51. "Asthma Case Study", presented to primary care physician. Sponsored by AstraZeneca Pharmaceuticals, Dayton, Ohio, March 26, 2002.
  52. "ARIA", presented to primary care physicians and allergists. Sponsored by Schering/Key Pharmaceuticals, Dayton, Ohio, March 28, 2002.
  53. "Allergic and Non-Allergic Rhinitis and its impact on Asthma", presented to students and faculty of Wright State University. Sponsored by GlaxoSmithKline Pharmaceuticals, Dayton, Ohio, May 21, 2002.
  54. "Update Treatment Options for Seasonal and Perennial Allergic Rhinitis", presented to primary care physicians. Sponsored by Pfizer and UCB Pharmaceuticals, Dayton, Ohio, May 22, 2002.
  55. "Allergic and Non Allergic Rhinitis and its impact on Asthma", presented to family medicine residents. Sponsored by GlaxoSmithKline Pharmaceuticals, Good Samaritan Hospital, Dayton, Ohio, and June 5, 2002.
  56. "Allergic Rhinitis", presented to primary care physicians. Sponsored by Shering Pharmaceuticals Mason, Ohio, Ohio, June13, 2002.
  57. "Biological Consequences of Leukotrienes", presented to primary care physicians. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, August 13, 2002.
  58. "Case Studies in the Management of Rhinitis", presented to primary care physicians. Sponsored by AstraZeneca Pharmaceuticals, Dayton, Ohio, August 14, 2002.
  59. "Treatment Options for Allergic Rhinitis and Chronic Idiopathic Urticaria", presented to primary care providers. Sponsored by Schering Pharmaceuticals, Sidney, Ohio, August 19, 2002.
  60. "Treatments Options for Allergic Rhinitis and Chronic Idiopathic Urticaria", presented to primary care provider. Sponsored by Schering Pharmaceuticals, Dayton, Ohio, September 26, 2002.
  61. "Treatment Options for Persistent Asthma", presented to primary care physicians. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, October 1, 2002.
  62. "Case studies in the management of Rhinitis", presented to primary care physicians. Sponsored by AstraZeneca Pharmaceuticals, Dayton, Ohio, November 6, 2002.
  63. "Asthma" presented to internal medicine residents. Sponsored by Merck Pharmaceuticals, Miami Valley Hospital, Dayton, Ohio, February 3, 2003.
  64. "Spring Allergy Update", presented to primary care physicians. Sponsored by Aventis Pharmaceuticals, Dayton, Ohio, March 27, 2003.
  65. "Effectively treating the nasal and non-nasal symptoms of Allergic Rhinitis", presented to primary care physicians. Sponsored by Schering Pharmaceuticals, Sidney, Ohio, April 9, 2003
  66. "Asthma: From Etiology to Treatment", presented to residents and attending of Internal Medicine. Sponsored by Merck Pharmaceuticals, Kettering Medical Center, Dayton, Ohio, August 27, 2003.
  67. "Approaches to Pediatric Asthma in the 21st Century", a CME Tele-lecture Program presented to pediatricians from Ohio. Sponsored by Merck Pharmaceuticals, October 15, 2003.
  68. "Overview of Allergic Rhinitis", given to Internal Medicine residents at the VA Hospital, Dayton, Ohio, November 4, 2003.
  69. "Primary Immunodeficiencies", presented to Internal Medicine residents. Sponsored by Aventis Pharmaceuticals, Miami Valley Hospital, Dayton, Ohio, December 1, 2003.
  70. "Effectively Treating the Nasal and Non-Nasal Symptoms of Allergic Rhinitis", presented to primary care physicians. Sponsored by Schering Pharmaceuticals, New Bremen, Ohio, March 4, 2004.
  71. "Spring Allergy Updated", presented to primary care physicians and nurses. Sponsored by Aventis Pharmaceuticals, Dayton, Ohio, March 31, 2004.
  72. "Spring Allergy Update Nasal Steroids", presented to primary care physicians and pulmonologists. Sponsored by Aventis Pharmaceuticals, West Chester, Ohio, May 13, 2004.
  73. "Challenges in treating Allergic Rhinitis", presented to primary care physicians. Sponsored by Pfizer, Dayton, Ohio, May 18, 2004.
  74. "Overview of Allergic Rhinitis", presented to physicians of multiple specialties. Sponsored by Schering Pharmaceutical, Greene Memorial Hospital, Xenia, Ohio, May 24, 2004.
  75. "Seasonal Allergic Rhinitis" presented to residents of Family of Medicine. Sponsored by Aventis Pharmaceuticals, Good Samaritan Hospital, Dayton, Ohio, June 9, 2004.
  76. "Challenges in Treating Allergic Rhinitis", presented to primary care physicians, and nurses. sponsored by Pfizer Pharmaceuticals, Dayton, Ohio, July 28, 2004.
  77. "Allergic Rhinitis and Asthma", case presentation, presented to family medicine residents. Grandview Hospital, Dayton, Ohio, August 31, 2004.
  78. "Astelin" consultant meeting moderator, given to allergists, otolaryngologists and primary care physicians. Sponsored by Medpoint Pharmaceuticals, West Chester, Ohio, September 27, 2004.
  79. "Role of Astelin Nasal spray in Allergic Rhinitis", presented to primary care physicians. Sponsored by Medpoint Pharmaceuticals, Dayton, Ohio, October 6, 2004.
  80. "Asthma", presented to primary care physicians. Sponsored by Primary Care Network for CME credits, Dayton, Ohio, October 13, 2004.
  81. "Challenges in Treating Allergic Rhinitis", presented to primary care physicians and otolaryngology physicians. Sponsored by Pfizer Pharmaceuticals, Dayton, Ohio, October 27, 2004.
  82. "Efficacy of Clarinex in the Treatment of Allergic Rhinitis", presented to primary care physicians. Sponsored by Schering Pharmaceuticals, Springboro, Dayton, Ohio, February 24, 2005.
  83. "Singulair", presented to pharmacists. Sponsored by Merck Pharmaceutical, Springboro, Ohio, March 8, 2005.
  84. "Efficacy of Clarinex in the treatment of Allergic Rhinitis, presented to primary care physicians. Sponsored by Schering Pharmaceuticals, Springboro, Ohio, March 16, 2005.
  85. "Update on the Treatment of Allergic Rhinitis", presented to primary care physicians, otolaryngologist, physician assistants and nurses. Sponsored by Sanofi-Aventis, Dayton, Ohio, April 20, 2005.
  86. "New insights in the treatment of Small Airway Disease", presented to primary care physicians. Sponsored by Ivax Laboratories Inc., Dayton, Ohio, September 7, 2005.
  87. "Management of Nasal Congestion Associated with Allergic Rhinitis", presented to primary care physicians. Sponsored by Schering-Plough Pharmaceuticals, Dayton, Ohio, September 14, 2005.
  88. "Treating Nasal Congestion in Allergic Rhinitis", presented to primary care physicians, physician assistants and nurses. Sponsored by Schering-Plough Pharmaceuticals, Dayton, Ohio, March 29, 2006.
  89. "Asthma: Phenotypes, Allergy and Anti-IgE", presented to the Kentucky Allergy Society. Sponsored by Genentech, Louisville, Kentucky, September 15, 2006,
  90. Round table discussion about Severe Asthma, presented to primary care physicians. Sponsored by Genentech, Wright Patterson Air Force Base Fairborn, Ohio, on February 1, 2007.
  91. "The consequences of Untreated Allergic Rhinitis", presented to primary care physicians. Sponsored by Pfizer Pharmaceuticals, Dayton, Ohio, February 22, 2007.
  92. "Congestion: A Management Challenge in Allergic Rhinitis", presented to primary care physicians. Sponsored by Schering-Plough Pharmaceuticals, Dayton, Ohio, February 26, 2007.
  93. "Congestion: A Management Challenge in Allergic Rhinitis", presented to primary care physicians. Sponsored by Schering-Plough Pharmaceuticals, Dayton, Ohio, March 12, 2007.
  94. Round table discussion about Severe Asthma, presented to primary care physicians. Sponsored by Genentech, Green Memorial Hospital, Xenia, Ohio, March 26, 2007.
  95. "Management of Inflammation and Bronchoconstriction in Adults with Asthma", presented to primary care physicians. Sponsored by GlaxoSmithKline Pharmaceuticals, Troy, Ohio, April 18, 2007.
  96. "Management of Inflammation and Bronchoconstriction in Adults with Asthma", presented to primary care physicians and pulmonologist. Sponsored by GlaxoSmithKline Pharmaceuticals, Celina, Ohio, June 6, 2007.
  97. "Management of Inflammation and Bronchoconstriction in Adults with Asthma", presented to pediatricians. Sponsored by GlaxoSmithKline Pharmaceuticals, Springboro, Ohio, June 12, 2007.
  98. "Management of Inflammation and Bronchoconstriction in Adults with Asthma", presented to pediatricians. Sponsored by GlaxoSmithKline Pharmaceuticals in Dayton, Ohio, July10, 2007.
  99. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Dayton, Ohio, July18, 2007.
  100. "Management of Inflammation and Bronchoconstriction in Adults with Asthma", presented to primary care physicians. Sponsored by GlaxoSmithKline Pharmaceuticals, Dayton, Ohio, July19, 2007.
  101. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals in Cincinnati, Ohio, July 30, 2007.
  102. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Springboro, Ohio, August 6, 2007.
  103. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Piqua, Ohio, August 21, 2007.
  104. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Dayton, Ohio, August 30, 2007.
  105. "Management of Inflammation and Bronchoconstriction in Adults with Asthma", presented to primary care physicians. Sponsored by GlaxoSmithKline Pharmaceuticals, Dayton, Ohio, August 31, 2007.
  106. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Vandalia, Ohio, September 11, 2007.
  107. "The Role of Symbicort in Asthma Control", presented to specialty care physicians. Sponsored by Astra Zeneca, Centerville, Ohio, September 19, 2007.
  108. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Dayton, Ohio, September 28, 2007.
  109. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Dayton, Ohio, October 5, 2007.
  110. "Management of Inflammation and Bronchoconstriction in Adults with Asthma", presented to primary care physicians. Sponsored by GlaxoSmithKline, Dayton, Ohio, October 19, 2007.
  111. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Troy, Ohio, October 26, 2007.
  112. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca, Oxford, Ohio, November 29, 2007.
  113. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Dayton, Ohio, December 17, 2007.
  114. "Congestion: A Management Challenge in Allergic Rhinitis", presented to primary care physicians. Sponsored by Schering-Plough Pharmaceuticals, Kettering, Ohio, February 4, 2008.
  115. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Troy, Ohio, February 14, 2008.
  116. "The Treatment of Chronic Idiopathic Urticaria", presented to primary care physicians. Sponsored by Sanofi-Adventis Pharmaceuticals, Beavercreek, Ohio, February 25, 2008
  117. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Wilmington, Ohio, February 27, 2008.
  118. "The Role of Symbicort in Asthma Control", presented to primary care physicians. Sponsored by Astra Zeneca Pharmaceuticals, Sidney, Ohio, March 3, 2008.
  119. "Relieving Multiple Allergy Symptoms with One Medicine", presented to primary care physicians. Sponsored by GlaxoSmithKline Pharmaceuticals, Dayton, Ohio, April 17, 2008.
  120. "Congestion: A Management Challenge in Allergic Rhinitis", presented to primary care physicians. Sponsored by Schering-Plough Pharmaceuticals, Beavercreek, Ohio, April 23, 2008.
  121. "Congestion: A Management Challenge in Allergic Rhinitis", presented to otolaryngology physicians. Sponsored by Schering-Plough Pharmaceuticals, Beavercreek, Ohio, August 11, 2008.
  122. "Evidence Based Approach to the Treatment of Asthma", presented to pharmacists. Sponsored by GlaxoSmithKline Pharmaceuticals in Beavercreek, Ohio, September 25, 2008.
  123. "Heterogeneity in Asthma", presented to local allergists. Sponsored by Merck Pharmaceuticals, Beavercreek, Ohio, October 22, 2008.
  124. "Management/Control- Anti- IgE Therapy and Asthma Management- An Update", presented to family practice physicians. Sponsored by Novartis Pharmaceuticals, Middletown, Ohio, October 23, 2008.
  125. "Entopy", presented to local otolaryngologist. Sponsored by Sanofi-Aventis, Beavercreek, Ohio, December 2, 2008.
  126. "Entopy: Role of local IgE in Upper Airway Disorders". Seminar given at the 65th Annual Conference of American Academy of Allergy, Asthma & Immunology, Washington D.C., March 14, 2009.
  127. "Management and Treatment of Asthma - Guidelines for IgE Mediated Therapy", presented to medical students and residents from Grandview Hospital. Sponsored by Genentech, Dayton, Ohio, October 27, 2009.
  128. "Management and Treatment of Asthma - Guidelines for IgE Mediated Therapy", presented to pediatricians. Sponsored by Genentech, Beavercreek, Ohio, November 23, 2009.
  129. "Management and Treatment of Asthma. Guidelines and Update and Implications for IgE mediated Therapy", presented to pediatricians. Sponsored by Genentech, Dayton, Ohio, February 26, 2010.
  130. "Clinical Consideration in the Assessment and Management of Asthma", presented to allergists and immunologists. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, April 20, 2011.
  131. "Clinical Considerations in the Assessment and Management of Asthma", presented to allergists and immunologists. Sponsored by Merck Pharmaceuticals, Dayton, Ohio, April 11, 2012.

Interviews:

  1. Interviews at local TV stations (four times). Topics: Allergies, Malignancy Associated With Hismanal and Seldane, Fatal Allergic Reaction to Peanuts, and When Your Child Has Allergies. (1993-1995)
  2. Radio Talk show at WHIO. Topic: Asthma. Dayton, Ohio, October 28, 1995.
  3. Dayton Daily News, “Allergies Bloom”by Cheryl L. Reed, Dayton, Ohio, spring 1995.
  4. Dayton Daily News, “Ragweed Allergy Season Coming Up”, by Anne Kallar, Dayton, Ohio, August 22, 1995.
  5. Radio talk show at WHIO. Topic: Flares of Asthma in the winter. Dayton, Ohio, January 13, 1996.
  6. Interview by Ricky Boyde. GTV Viacom Channel 19. “To Your Health”. Topic: Asthma. Dayton, Ohio, March 4, 1996.
  7. Interview by Jerry Halasz. Radio talk show at WHIO. Topic: Asthma and Allergy Season. Dayton, Ohio, May 18, 1996.
  8. Interview: Channel 2 WDTN. Topic: Allergy in the summer. Dayton, Ohio, July 19, 1996.
  9. Interview: Dayton Daily News, “Ragweed Arrives Early”, by Jim DeBrosse, Dayton, Ohio, August 14, 1996.
  10. Interview: Channel 2 WDTN. Topic: Ozone and Asthma. Dayton, Ohio, June 24, 1997.
  11. Interview: Channel 22. Topic: “Impact of El Nino,” Dayton, Ohio, May 22, 1998.
  12. Dayton Daily News, “City Scratches Right to the Top Ten”, by Kavita Kumar, Dayton, Ohio, July 8, 1998.
  13. Dayton Daily News, “Nature’s Unstoppable Menace”, by Laura Dempsey, Dayton, Ohio, July 14, 1998.
  14. Dayton Daily News, “Peanut-Free Zones Sound Nutty”, by D. L. Stewart, Dayton, Ohio September 8, 1998.
  15. Dayton Daily News, “Warm Spells Linger”, by James Cummings, Dayton, Ohio, December 2, 1998.
  16. Interview: “Nasalcrom in Allergic Rhinitis”, by Molly Hughes, Channel 2 WDTN. Dayton, Ohio, March 23, 1999
  17. Interview: “Allergies in Spring”, by Cristen Herbold, Channel 2 WDTN. Dayton, Ohio, May, 1999.
  18. Interview: “Allergies and the Weather”, by Cristen Herbold, Channel 2 WDTN, Dayton, Ohio, September 2, 1999.
  19. Interview: “Ragweed Allergies”, by Roberta English, Channel 22 WKEF, Dayton, Ohio, and September 13, 1999.
  20. Interview: “Hay Fever Season”, by Marsha Bonhart, Channel 2 WDTN, Dayton, Ohio, August 25, 2000.
  21. Interview: “Allergies and Asthma”, by Jamie Krumhausen, Channel 2 WDTN, Dayton, Ohio, May 18, 2001.
  22. Interview: “Personal experience of patients who think they are allergic and are not by allergy testing”, by Tiffany Woods, Channel 22(NBC and FOX45), Dayton, Ohio, May 30, 2001.
  23. Interview: “Hay Fever Season”, by Jamie Krumhausen, Channel 2 WDTN, Dayton, Ohio, September 6, 2001.
  24. Interview: “Allergies: Questions and Answers”, by Marsha Bonhart, Channel 2 WDTN, Dayton, Ohio, May 7, 2002.
  25. Dayton Daily News “Nose Woes Signal Pollution Saturation”, by Margo Rutledge Kissell, Dayton, Ohio, June 9, 2004.
  26. Interview: “To Your Health”, by Ricky Boyd, Channel 10, Dayton, Ohio, April 10, 2006.
  27. Interview: “Spring Allergies”, by Holly Samuels, Channel 2 WDTN, Dayton, Ohio, April 3, 2008.
  28. Interview: “Change in Propellants for Asthma Inhalers”, by Chelby Kosto, Channel 2 WDTN, Dayton, Ohio, June 24, 2008.
  29. Interview: “Hay Fever in the Miami Valley”, by Erik Zarnitz, Channel 2, WDTN, Dayton, Ohio, March 30, 2009.
  30. Interview: “How You Can Stop Ragweed Sneezes”, by Erik Zamitz, Channel 2, WDTN, Dayton, Ohio, August 25, 2009.
  31. Interview: “ Allergies in the Miami Valley”, by Marsha Bonhart, Channel 2, WDTN, Dayton, Ohio, April 13, 2010.
  32. Interview: “Spring Allergies”, by Kimberly Thompson, Channel 7, WHIO, Dayton, Ohio, April 16, 2010.
  33. Interview: “Spring Allergy Alert”, by Tara Hastings, Channel 2, WDTN, Dayton, Ohio., April 4, 2011.
  34. Interview: “How To Survive Allergy Season”, by Dave Larsen, Dayton Daily News, Dayton, Ohio, May 12, 2011.
  35. Interview: “Allergist vs Over the Counter Medications”, by Andrew Buck Michael, Fox 45, WKEF/WRGT, Dayton, Ohio, May 20, 2011.
  36. Interview: “ Advice for Treating, Living with Asthma”, by Aaron Epple, Dayton Daily News, Dayton, Ohio, July 11, 2011.
  37. Interview: “Coping with The Coming Ragweed Season”, by Christopher Cerenelli, Channel 22, WKEF, Dayton, Ohio , August 12, 2011.
  38. Interview:” Dayton #10 Allergy Capital in America”, by Christopher Cerenelli, Channel 22, WKEF, Dayton, Ohio, March 20,2012.
  39. Interview: “Rising ragweed on the way”, by Tara Hastings, Channel 2, WDTN, Dayton, Ohio, August 28, 2012.
  40. Interview: “Reasons for Tough Allergy Seasons”, by Lee Ann Okuly, WRGT Fox 45 Dayton, Ohio, April 24, 2013.
  41. Interview: “Ragweed Season Arrives with a Vengeance”, by Jamar Black, WDTN-Channel 2, Dayton, Ohio, August 14, 2013.
  42. Interview: “Epinephrine halts allergic reactions”, by Patricia Ann Speelman, Sidney Daily News, Sidney, Ohio, December 13, 2013.
  43. Interview: “Spring Allergies”, by Jamar Black, WDTN-Channel 2, Dayton, Ohio March 20, 2014.
  44. Interview: “Spring Allergies”, Emily Wood, Fox 45, Dayton, Ohio, April 2, 2014
  45. Interview: “Spring Allergies”, Eric Pointer, WDTN-Channel 2, Dayton, Ohio, May 7, 2015.
  46. Interview: “Ragweed Season Almost Here”, Tara Hastings, WDTN-Channel 2, Dayton, Ohio September 2, 2015.
  47. Interview: “Spring Allergies”, Lauren Stephenson, Cox Media, WHIO-Channel 7, Dayton, Ohio, April 20, 2016.
  48. Interview: “Spring Allergy Season Already Kicks in For Many”, Lauren Stephenson, Cox Media, Dayton Daily News, Dayton, Ohio, April 22, 2016.
  49. Interview: “Allergy Sufferers See Symptoms Worsen”, Kirstie Zontini, WHIO Channel 7, Dayton, Ohio, June 1, 2016.

LANGUAGES:

Spanish - Native language
English - Fluently speaks, writes and reads

 

Allergy & Asthma Centre Logo

© Allergy & Asthma Centre of Dayton - All Rights Reserved. Web published by Marketing Options, LLC